Stock Market News
Private placement sees Tekcapital hold 39pc of Belluscura
Intellectual property investment group Tekcapital announced on Wednesday that Belluscura has concluded a private placement to raise approximately $1.33m through Dowgate Capital Stockbrokers, and converted loans equal to approximately $0.27m to equity under the same terms as the private placement.
The AIM-traded company said it invested $0.25m in the private placement and converted loans to Belluscura of $0.21m to equity.
As a result, Tekcapital's ownership interest in Belluscura was now 8,129,488 shares, representing approximately 39% of the issued share capital.
Under the terms of the private placement, Tekcapital was issued with a three-year warrant to purchase 1,273,078 new shares in Belluscura at 13p per share.
This Private Placement was priced at 18 cents (13p) per share, giving Belluscura a post-money valuation of approximately $3.7m.
Belluscura said it would extend the private placement for an additional 90 days to enable current shareholders and additional investors to participate.
"Belluscura was established in the UK in December 2015 to provide premium proprietary medical devices at affordable prices," Tekcapital's board explained.
The company had already launched three products with two more products in development.
Tekcapital said the proceeds of the private placement would be used for further investment in Belluscura's products in development, specifically the 'CURV' oxygen concentrator and 'Snap III' level of consciousness monitor, and for general working capital purposes.
"We are very pleased to announce this private placement," said Belluscura CEO Bob Rauker.
"The funds will allow Belluscura to continue with its mission to provide premium, proprietary medical devices at affordable prices."
The AIM-traded company said it invested $0.25m in the private placement and converted loans to Belluscura of $0.21m to equity.
As a result, Tekcapital's ownership interest in Belluscura was now 8,129,488 shares, representing approximately 39% of the issued share capital.
Under the terms of the private placement, Tekcapital was issued with a three-year warrant to purchase 1,273,078 new shares in Belluscura at 13p per share.
This Private Placement was priced at 18 cents (13p) per share, giving Belluscura a post-money valuation of approximately $3.7m.
Belluscura said it would extend the private placement for an additional 90 days to enable current shareholders and additional investors to participate.
"Belluscura was established in the UK in December 2015 to provide premium proprietary medical devices at affordable prices," Tekcapital's board explained.
The company had already launched three products with two more products in development.
Tekcapital said the proceeds of the private placement would be used for further investment in Belluscura's products in development, specifically the 'CURV' oxygen concentrator and 'Snap III' level of consciousness monitor, and for general working capital purposes.
"We are very pleased to announce this private placement," said Belluscura CEO Bob Rauker.
"The funds will allow Belluscura to continue with its mission to provide premium, proprietary medical devices at affordable prices."
Related share prices |
---|
Tekcapital (TEK) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price